{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:03:50Z","timestamp":1785189830692,"version":"3.55.0"},"reference-count":56,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bill &amp; Melinda Gates Foundation and Flu Lab","award":["OPP1214161"],"award-info":[{"award-number":["OPP1214161"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>The elicitation of broadly neutralizing antibodies (bnAbs) is a major goal of vaccine design for highly mutable pathogens, such as influenza, HIV, and coronavirus. Although many rational vaccine design strategies for eliciting bnAbs have been devised, their efficacies need to be evaluated in preclinical animal models and in clinical trials. To improve outcomes for such vaccines, it would be useful to develop methods that can predict vaccine efficacies against arbitrary pathogen variants. As a step in this direction, here, we describe a simple biologically motivated model of antibody reactivity elicited by nanoparticle-based vaccines using only antigen amino acid sequences, parametrized with a small sample of experimental antibody binding data from influenza or SARS-CoV-2 nanoparticle vaccinations. Results: The model is able to recapitulate the experimental data to within experimental uncertainty, is relatively insensitive to the choice of the parametrization\/training set, and provides qualitative predictions about the antigenic epitopes exploited by the vaccine, which are testable by experiment. For the mosaic nanoparticle vaccines considered here, model results suggest indirectly that the sera obtained from vaccinated mice contain bnAbs, rather than simply different strain-specific Abs. Although the present model was motivated by nanoparticle vaccines, we also apply it to a mutlivalent mRNA flu vaccination study, and demonstrate good recapitulation of experimental results. This suggests that the model formalism is, in principle, sufficiently flexible to accommodate different vaccination strategies. Finally, we show how the model could be used to rank the efficacies of vaccines with different antigen compositions. Conclusions: Overall, this study suggests that simple models of vaccine efficacy parametrized with modest amounts of experimental data could be used to compare the effectiveness of designed vaccines.<\/jats:p>","DOI":"10.3390\/antib14010006","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:44:23Z","timestamp":1737024263000},"page":"6","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phenomenological Modeling of Antibody Response from Vaccine Strain Composition"],"prefix":"10.3390","volume":"14","author":[{"given":"Victor","family":"Ovchinnikov","sequence":"first","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Karplus","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA"},{"name":"Laboratoire de Chimie Biophysique, ISIS, Universit\u00e9 de Strasbourg, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.15585\/mmwr.mm7110a1","article-title":"Interim Estimates of 2021\u201322 Seasonal Influenza Vaccine Effectiveness\u2013United States, February 2022","volume":"71","author":"Chung","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.5005\/jp-journals-10071-23649","article-title":"R0 and Re of COVID-19: Can We Predict When the Pandemic Outbreak Will Be Contained?","volume":"24","author":"Achaiah","year":"2020","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.chom.2021.06.016","article-title":"The Success of SARS-CoV-2 Vaccines and Challenges Ahead","volume":"29","author":"Subbarao","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 MRNa Vaccine Design Enabled by Prototype Pathogen Preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems Vaccinology of the BNT162b2 MRNa Vaccine in Humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","article-title":"Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain That Escape Antibody Recognition","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"COVID-19 Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"taab124","DOI":"10.1093\/jtm\/taab124","article-title":"The Reproductive Number of the Delta Variant of SARS-CoV-2 Is Far Higher Compared to the Ancestral SARS-CoV-2 Virus","volume":"28","author":"Liu","year":"2021","journal-title":"J. Travel Med."},{"key":"ref_10","unstructured":"(2024, November 29). HIV AIDS Asia Pacific Research Statistical Data Information Resources AIDS Data Hub. UNAIDS Data Reference 2021. Available online: https:\/\/www.aidsdatahub.org\/resource\/unaids-data-2021."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.1094620","article-title":"A Sound Rationale Needed for Phase III HIV-1 Vaccine Trials","volume":"303","author":"Burton","year":"2004","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coviro.2017.03.002","article-title":"Tackling Influenza with Broadly Neutralizing Antibodies","volume":"24","author":"Corti","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.coviro.2021.09.015","article-title":"Strategies for Eliciting Multiple Lineages of Broadly Neutralizing Antibodies to HIV by Vaccination","volume":"51","author":"Mu","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of Broadly Cross-Reactive Antibody Responses to the Influenza Ha Stem Region Following H5N1 Vaccination in Humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.03152-15","article-title":"Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses","volume":"90","author":"Carter","year":"2016","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E7039","DOI":"10.1073\/pnas.1614940113","article-title":"Optimal Immunization Cocktails Can Promote Induction of Broadly Neutralizing Abs Against Highly Mutable Pathogens","volume":"113","author":"Shaffer","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","unstructured":"Ives, S., B\u00fcrckert, J.P., Pettus, C., Pe\u00f1ate, K., Hovde, R., Bayless, N., Shanghavi, D., Glanville, K., Calgua, E., and Youssef, S. (2021). A General Solution to Broad-Spectrum Vaccine Design for Rapidly Mutating Viruses. Res. Sq., submitted."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic Nanoparticle Display of Diverse Influenza Virus Hemagglutinins Elicits Broad B Cell Responses","volume":"20","author":"Kanekiyo","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41467-020-14579-4","article-title":"Glycan Repositioning of Influenza Hemagglutinin Stem Facilitates the Elicitation of Protective Cross-Group Antibody Responses","volume":"11","author":"Hutchinson","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cohen, A., Yang, Z., Gnanapragasam, P., Ou, S., Dam, K., Wang, H., and Bjorkman, P. (2021). Construction, Characterization, and Immunization of Nanoparticles That Display a Diverse Array of Influenza Ha Trimers. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247963"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic Nanoparticles Elicit Cross-Reactive Immune Responses to Zoonotic Coronaviruses in Mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.copbio.2018.01.006","article-title":"Induction of Broadly Neutralizing Antibodies in Germinal Centre Simulations","volume":"51","author":"Robert","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cell.2015.01.027","article-title":"Manipulating the Selection Forces During Affinity Maturation to Generate Cross-Reactive HIV Antibodies","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ovchinnikov, V., and Karplus, M. (2022). A Coarse-Grained Model of Affinity Maturation Indicates the Importance of B-Cell Receptor Avidity in Epitope Subdominance. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.816634"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Wang, S. (2017). Optimal Sequential Immunization Can Focus Antibody Responses Against Diversity Loss and Distraction. PLoS Comput. Biol., 13.","DOI":"10.1371\/journal.pcbi.1005336"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102979","DOI":"10.1016\/j.isci.2021.102979","article-title":"Ymir: A 3D Structural Affinity Model for Multi-Epitope Vaccine Simulations","volume":"24","author":"Robert","year":"2021","journal-title":"iScience"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Conti, S., Ovchinnikov, V., Chakraborty, A., Karplus, M., and Sprenger, K. (2022). Multiscale Affinity Maturation Simulations to Elicit Broadly Neutralizing Antibodies Against HIV. PLoS Comput. Biol., 18.","DOI":"10.1371\/journal.pcbi.1009391"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10-1128","DOI":"10.1128\/mBio.02810-18","article-title":"Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages","volume":"10","author":"Corbett","year":"2019","journal-title":"mBio"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e33038","DOI":"10.7554\/eLife.33038","article-title":"Role of Framework Mutations and Antibody Flexibility in the Evolution of Broadly Neutralizing Antibodies","volume":"7","author":"Ovchinnikov","year":"2018","journal-title":"eLife"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1016\/j.eswa.2010.09.005","article-title":"A New Encoding Technique for Peptide Classification","volume":"38","author":"Nanni","year":"2011","journal-title":"Expert Syst. Appl."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.185.4154.862","article-title":"Amino Acid Difference Formula to Help Explain Protein Evolution","volume":"185","author":"Grantham","year":"1974","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1073\/pnas.0408677102","article-title":"Solving the Protein Sequence Metric Problem","volume":"102","author":"Atchley","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/bip.20296","article-title":"A New Set of Amino Acid Descriptors and Its Application in Peptide QSARs","volume":"80","author":"Mei","year":"2005","journal-title":"Biopolymers"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/bioinformatics\/btz895","article-title":"Antibody Complementarity Determining Region Design Using High-Capacity Machine Learning","volume":"36","author":"Liu","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_35","unstructured":"MATLAB (2010). Version 7.10.0 (R2010a), The MathWorks Inc."},{"key":"ref_36","unstructured":"Eaton, J.W., Bateman, D., Hauberg, S., and Wehbring, R. (2024, November 29). GNU Octave Version 6.3.0 Manual: A High-Level Interactive Language for Numerical Computations. Available online: https:\/\/docs.octave.org\/octave-6.3.0.pdf."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD\u2014Visual Molecular Dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.02005-07","article-title":"The Influenza Virus Resource at the National Center for Biotechnology Information","volume":"82","author":"Bao","year":"2008","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1126\/science.1186430","article-title":"Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus","volume":"328","author":"Xu","year":"2010","journal-title":"Science"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2019.03.048","article-title":"Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism","volume":"177","author":"Watanabe","year":"2019","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","article-title":"Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies","volume":"182","author":"Barnes","year":"2020","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","article-title":"Studies in Humanized Mice and Convalescent Humans Yield a SARS-CoV-2 Antibody Cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A Multivalent Nucleoside-Modified MRNa Vaccine Against All Known Influenza Virus Subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/acs.jcim.7b00650","article-title":"KDEEP: Protein\u2013Ligand Binding Affinity Prediction Via 3D-Convolutional Neural Networks","volume":"58","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/acscentsci.8b00507","article-title":"PotentialNet for Molecular Property Prediction","volume":"4","author":"Feinberg","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"100406","DOI":"10.1016\/j.patter.2021.100406","article-title":"Antibody Structure Prediction Using Interpretable Deep Learning","volume":"3","author":"Ruffolo","year":"2022","journal-title":"Patterns"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ni.3684","article-title":"Defining the Antibody Cross-Reactome Directed Against the Influenza Virus Surface Glycoproteins","volume":"18","author":"Nachbagauer","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_49","unstructured":"Murphy, K. (2012). Janeway\u2019s Immunobiology, Garland Science. [8th ed.]."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e2018338118","DOI":"10.1073\/pnas.2018338118","article-title":"Design of Immunogens to Elicit Broadly Neutralizing Antibodies Against HIV Targeting the CD4 Binding Site","volume":"118","author":"Conti","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JVI.02108-09","article-title":"Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies","volume":"84","author":"Seaman","year":"2010","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate Structure Prediction of Biomolecular Interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"eadl2528","DOI":"10.1126\/science.adl2528","article-title":"Generalized Biomolecular Modeling and Design with RoseTTAFold All-Atom","volume":"384","author":"Krishna","year":"2024","journal-title":"Science"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1109\/TPAMI.2021.3095381","article-title":"ProtTrans: Toward Understanding the Language of Life Through Self-Supervised Learning","volume":"44","author":"Elnaggar","year":"2022","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-Scale Prediction of Atomic-Level Protein Structure with a Language Model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"17221","DOI":"10.1073\/pnas.1920321117","article-title":"Original Antigenic Sin Priming of Influenza Virus Hemagglutinin Stalk Antibodies","volume":"117","author":"Arevalo","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/14\/1\/6\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:30:04Z","timestamp":1759919404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/14\/1\/6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["antib14010006"],"URL":"https:\/\/doi.org\/10.3390\/antib14010006","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]}}}